Scientific Programme, ePosters & Abstracts

ESPE Abstracts (2023) 97 P1-345

ESPE2023 Poster Category 1 Pituitary, Neuroendocrinology and Puberty (73 abstracts)

45 mg Subcutaneous Leuprolide Acetate Suppressed Unstimulated Luteinizing Hormone (LH) to Prepubertal Concentrations

Bradley Miller 1 , Deborah Boldt-Houle 2 , Rhea Daugherty 2 & Stuart Atkinson 2


1Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, MHealth Fairview Masonic Children’s Hospital, Minneapolis, USA. 2Tolmar, Inc., Buffalo Grove, USA


Background: There is evidence that unstimulated LH concentrations may be appropriate to monitor hormone suppression in children with central precocious puberty (CPP) during treatment with gonadotropin-releasing hormone agonists (GnRHa). Literature suggests that unstimulated LH concentrations <0.3 and >0.8 IU/L are prepubertal and clearly pubertal, respectively. We present secondary analyses of unstimulated LH suppression data from the pivotal trial of the first small-volume, long-acting, subcutaneously administered GnRHa for CPP (FENSOLVI®), with the goal of assessing whether the study drug effectively suppressed unstimulated LH to prepubertal concentrations.

Methods: Sixty-two children (60 girls, 2 boys) with treatment-naïve CPP received 2 doses of 45mg subcutaneous leuprolide acetate at 24-week intervals. Blood samples used to assess unstimulated LH concentrations were taken at screening, baseline, and weeks 4, 12, 20, 24, 36, 44, and 48. LH concentrations were assessed using a validated central Cobas ECLIA assay with a lower limit of detection of 0.1 IU/L.

Results: Proportions of children who achieved unstimulated LH <0.3 and <0.8 IU/L and their mean estradiol (E2) concentrations are summarized in Table 1. Proportions of children with various target unstimulated LH at week 24 are summarized in Table 2.

Table 1. Proportions (%) of Children Who Achieved Unstimulated LH <0.3 and 0.8 IU/L and Mean E2 (pg/mL) Across 48 Weeks
Week Unstimulated LH <0.3 Unstimulated LH <0.8
% of Children Mean E2 % of Children Mean E2
12 28 11.1 80 10.5
24 24 10.0 77 10.1
36 22 11.1 81 10.3
48 25 10.0 80 10.1
Table 2. Proportions (%) of Children Who Achieved Target Unstimulated LH at Week 24 in Each Children Subgroup
Target Unstimulated LH (IU/L) All Children n=62 Children with Stimulated LH ≥4 IU/L n=8 Children with Stimulated LH <4 IU/L n=54
<0.3 24 0 28
<0.6 63 38 67
<0.8 77 50 81
<1.0 84 50 89

Conclusions: Across 48 weeks, 77 to 81% of children maintained prepubertal unstimulated LH concentrations throughout treatment. These data indicate that 45mg subcutaneous leuprolide acetate effectively suppressed unstimulated LH to prepubertal concentrations. Additionally, 81% of children with pubertal suppression (stimulated LH <4 IU/L) had unstimulated LH <0.8 IU/L, suggesting that this cutoff may be suitable for monitoring treatment efficacy, especially if considered along with sex hormone levels.